semaglutide approved for cardiovascular Diabetes Drug Could Help Reduce Risk Events, Study Finds Semaglutide cardiovascular outcomes align more

First, we employed a rigorous target trial emulation framework with explicit protocol specification, new-user design, and landmark analysis to address immortal time bias [24,25,26,27]

Telehealth companies like Weight Watchers Clinic and LifeMD provide online consultations to determine eligibility for GLP-1s and other weight loss medications

For right now, there is no quick and easy test to check your genes for GLP-1 compatibility

36 ChoY

The success of peptide drugs in rare disease applications has demonstrated the value of orphan drug programs in bringing innovative therapies to patients with limited treatment options